Clinical Trials Directory

Trials / Unknown

UnknownNCT03153306

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Hainan People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Correction of hypovolemia is an important therapeutic measure,Even though there is no consensus regarding infusion rates, a plasma volume (PV) expander is often given at a fast rate to treat a suspected hypovolemia without delay which can be associated with aggravation of adverse interstitial accumulation of macromolecules and fluid, especially in inflammatory conditions such as sepsis.the smallest possible volumes for PV resuscitation to maintain normovolemia should be used to reduce the risk of simultaneous interstitial fluid accumulation. The investigators tested the hypothesis that a slow infusion rate of a PV expander results in better plasma expansion than a fast infusion rate to patients with severe sepsis or septic shock.

Conditions

Interventions

TypeNameDescription
DRUGalbuminTwo groups were formed at random for each fluid. In one group, 10ml/kg of 5% albumin was given over 1 hour (the "bolus" group), and in the other group, the same volume was given over 6 hrs (the"continuous" group)

Timeline

Start date
2016-06-01
Primary completion
2017-12-01
Completion
2018-03-01
First posted
2017-05-15
Last updated
2017-05-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03153306. Inclusion in this directory is not an endorsement.